Background-MR techniques have been very powerful in providing indicators of tissue perfusion, particularly in studies of cerebral ischemia. There is considerable interest in performing absolute perfusion measurements, with the aim of improving the characterization of tissue "at risk" of stroke. However, some important caveats relating to absolute measurements need to be taken into account. The purpose of this article is to discuss some of the issues involved and the potential implications for absolute cerebral blood flow measurements in clinical use. Summary of Comment-In bolus tracking MRI, deconvolution of the concentration-time course can in theory provide accurate quantification. However, there are several important assumptions in the tracer kinetic model used, some of which may be invalid in cerebral ischemia. These can introduce significant errors in perfusion quantification. Conclusions-Although we believe that bolus tracking MRI is a powerful technique for the evaluation of perfusion in cerebral ischemia, interpretation of perfusion maps requires caution; this is particularly true when absolute quantification is attempted. Work is currently under way in a number of centers to address these problems, and with appropriate modeling they may be overcome in the future. In the interim, we believe that it is necessary for users of bolus tracking perfusion data to be aware of the current technical limitations if they are to avoid misinterpretation or overinterpretation of their findings. Key Words: cerebral blood flow Ⅲ cerebral ischemia Ⅲ contrast media Ⅲ magnetic resonance imaging Ⅲ perfusion Ⅲ stroke T he term perfusion normally refers to the delivery of blood at the level of the capillaries, where exchange of oxygen and nutrients between blood and tissue takes place. When quantified, perfusion is measured in units of milliliters per 100 g per minute. MR techniques have been very powerful in providing indicators of tissue perfusion in the brain in the former, nonquantitative sense; indeed, they have been shown to contribute important new information not accessible by any other MR technique to date. One of the major applications has been in the assessment and management of patients with acute stroke, with numerous recent reports demonstrating the key role of perfusion MRI, mostly in combination with diffusion MRI since the latter is believed to provide an early marker of cytotoxic edema (see Reference 1 for a recent review).Many of the recent perfusion MRI studies have been concerned with predicting the eventual infarct volume in patients who have suffered an ischemic insult, with a major aim of selecting the most appropriate patients for possible therapeutic intervention. A large number of these studies have shown a regional mismatch between diffusion abnormality and perfusion deficit (eg, References 2-4), while others have shown the presence of perfusion abnormalities even in the absence of any abnormality on structural or diffusion MRI. [5][6][7] Although these areas of mismatch are generally believed to be...